Re: Grunwald et al.: Risk of Geographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2014;121:150-61)

被引:4
|
作者
Sophie, Raafay [1 ]
Wang, Jiangxia [1 ]
Campochiaro, Peter A. [1 ]
机构
[1] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
关键词
D O I
10.1016/j.ophtha.2013.12.043
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:E34 / E34
页数:1
相关论文
共 50 条
  • [1] Re:Grunwald et al.: Risk of Geographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2014; 121: 150-61) Reply
    Grunwald, Juan E.
    OPHTHALMOLOGY, 2014, 121 (07) : E35 - E35
  • [2] Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
    Grunwald, Juan E.
    Daniel, Ebenezer
    Huang, Jiayan
    Ying, Gui-shuang
    Maguire, Maureen G.
    Toth, Cynthia A.
    Jaffe, Glenn J.
    Fine, Stuart L.
    Blodi, Barbara
    Klein, Michael L.
    Martin, Alison A.
    Hagstrom, Stephanie A.
    Martin, Daniel F.
    OPHTHALMOLOGY, 2014, 121 (01) : 150 - 161
  • [3] Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
    Grunwald, Juan E.
    Pistilli, Maxwell
    Ying, Gui-shuang
    Maguire, Maureen G.
    Daniel, Ebenezer
    Martin, Daniel F.
    OPHTHALMOLOGY, 2015, 122 (04) : 809 - 816
  • [4] Geographic atrophy risk factors in participants of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)
    Grunwald, Juan
    Daniel, Ebenezer
    Ying, Gui-Shuang
    Huang, Jiayan
    Jaffe, Glenn
    Toth, Cynthia
    Hagstrom, Stephanie
    Fine, Stuart
    Martin, Daniel
    Maguire, Maureen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] BETA-PERIPAPILLARY ATROPHY AND GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS
    Kolomeyer, Anton M.
    Smith, Eli
    Daniel, Ebenezer
    Ying, Gui-Shuang
    Pan, Wei
    Pistilli, Max
    Grunwald, Juan
    Maguire, Maureen G.
    Kim, Benjamin J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (01): : 125 - 134
  • [6] Re: Keenan et al.: Progression of geographic atrophy in age-related macular degeneration (Ophthalmology. 2018;125:1913-1928)
    Smith, R. Theodore
    OPHTHALMOLOGY, 2019, 126 (05) : E39 - E40
  • [7] Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)
    Grunwald, Juan E.
    Pistilli, Maxwell
    Daniel, Ebenezer
    Ying, Gui-Shuang
    Fine, Stuart L.
    Martin, Daniel F.
    Maguire, Maureen G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with antivascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)
    Gillies, Mark C.
    Daien, Vincent
    Nguyen, Vuong
    Barthelmes, Daniel
    OPHTHALMOLOGY, 2017, 124 (03) : E31 - E32
  • [9] Re: Keenan et al.: Progression of geographic atrophy in age-related macular degeneration (Ophthalmology. 2018;125:1913-1928) REPLY
    Keenan, Tiarnan D.
    Agron, Elvira
    Chew, Emily Y.
    OPHTHALMOLOGY, 2019, 126 (05) : E40 - E41
  • [10] Emerging treatments for geographic atrophy in age-related macular degeneration
    Mahmoudzadeh, Raziyeh
    Hinkle, John W.
    Hsu, Jason
    Garg, Sunir J.
    CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (03) : 294 - 300